跳至主要内容
临床试验/NCT05840250
NCT05840250终止不适用

Improving Glucose Control and Self-Management in Adults With Type 2 Diabetes From Health Disparate Groups Using Continuous Glucose Monitoring and Education Support

Hackensack Meridian Health2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2023年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
10
试验地点
2
主要终点
Glycemic control

研究概览

简要总结

The study is a longitudinal single-arm prospective study design. Adult patients who are African American or Hispanic with type 2 diabetes mellitus will be recruited to participate in this study. The goal of the study is to determine if the use of a continuous glucose monitoring system will improve diabetes management in persons from health disparity background.

The subjects will be closely monitored for the first 3 months as they utilize the continuous glucose monitor and engage in diabetes education classes. They will then be followed for an additional 3 months to determine if they are able to maintain the same glucose control as experienced for the initial 3 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects with type 2 diabetes mellitus ≥18 years
  • African-American or Hispanic
  • with A1c ≥8% to ≤12%

排除标准

  • Patients with type 1 diabetes,
  • pregnant,
  • End-Stage Renal Disease,
  • recent use of any CGM within the last 12 months,
  • on steroid therapy and history of adhesive allergy.

结局指标

主要结局

Glycemic control

时间窗: At 6 months post enrollment

To investigate the effect of the Continuous Glucose Monitoring (CGM) device and educational support on the Glycemic control. Glycemic control will be measured based on the percent time that glucose is on target vs off target. On target is within the normal range of 70-180 mg/dL. Off target includes: \<54 mg/dL (critical low glucose); \< 70 mg/dL (low glucose); \>180 mg/dL (high glucose); and \>250 mg/dL (very high). The range at 24 weeks post enrollment will be compared to the baseline data that will be collected after the first 14 days (2 weeks).

A1c - Marker of overall glucose control

时间窗: At 6 months post enrollment

A1c levels measured at 24 weeks post enrollment will be compared to the baseline A1c level (measured at enrollment).

次要结局

  • ER visit(For the 3 months post enrollment)
  • Blood pressure(At 3 months post enrollment)
  • Weight(At 3 months post enrollment)
  • BMI(At 3 months post enrollment)
  • Hospital admissions(For the 3 months post enrollment)
  • Glycemic control - Episodes of hypoglycemia(For the 3 months post enrollment)
  • Diabetes self-care(At 3 months post enrollment)
  • Diabetes distress(At 3 months post enrollment)
  • Satisfaction with CGM device(At 3 months post enrollment)
  • Diabetes knowledge(At 3 months post enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验